A trial suggests that a dose of psilocybin, a compound found in psychedelic mushrooms, may be effective in treating stubborn depression. The study's findings imply that psilocybin can rewire the brain and break depressive cycles, although the scope of its potential applications is still being explored. It is unclear whether the treatment is specifically aimed at patients with certain conditions, such as advanced cancer, or if it has broader implications for depression treatment.